Published in Integr Cancer Ther on December 01, 2009
Entrainment of the mammalian cell cycle by the circadian clock: modeling two coupled cellular rhythms. PLoS Comput Biol (2012) 1.02
A clinically translatable mouse model for chemotherapy-related fatigue. Comp Med (2013) 0.94
The effect of melatonin on sleep and quality of life in patients with advanced breast cancer. Support Care Cancer (2015) 0.93
From quiescence to proliferation: Cdk oscillations drive the mammalian cell cycle. Front Physiol (2012) 0.83
Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression. Clin Transl Med (2015) 0.80
Systems Chronotherapeutics. Pharmacol Rev (2017) 0.75
Clinical Relevance of the First Domomedicine Platform Securing Multidrug Chronotherapy Delivery in Metastatic Cancer Patients at Home: The inCASA European Project. J Med Internet Res (2016) 0.75
Daily rhythms are retained both in spontaneously developed sarcomas and in xenografts grown in immunocompromised SCID mice. Chronobiol Int (2014) 0.75
Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol (2009) 13.52
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell (2009) 13.09
Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial. Lancet Oncol (2009) 5.05
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA (2008) 4.61
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med (2015) 4.24
Randomized phase III trial of temsirolimus versus sorafenib as second-line therapy after sunitinib in patients with metastatic renal cell carcinoma. J Clin Oncol (2013) 3.31
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol (2013) 3.19
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol (2012) 2.84
Failure to adhere to protocol specified radiation therapy guidelines was associated with decreased survival in RTOG 9704--a phase III trial of adjuvant chemotherapy and chemoradiotherapy for patients with resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys (2011) 2.54
Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response. J Clin Oncol (2006) 2.42
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial. Ann Surg Oncol (2011) 2.38
Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol (2004) 2.30
Host circadian clock as a control point in tumor progression. J Natl Cancer Inst (2002) 2.21
Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer. Ann Surg Oncol (2011) 2.05
Unresectable cholangiocarcinoma: comparison of survival in biliary stenting alone versus stenting with photodynamic therapy. Clin Gastroenterol Hepatol (2008) 2.03
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol (2006) 1.89
Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol (2012) 1.84
Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance. Mol Cell Proteomics (2012) 1.72
US intergroup anal carcinoma trial: tumor diameter predicts for colostomy. J Clin Oncol (2009) 1.65
miRNA profiling for clear cell renal cell carcinoma: biomarker discovery and identification of potential controls and consequences of miRNA dysregulation. J Urol (2011) 1.61
Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy. Cancer (2010) 1.52
Sunitinib in metastatic renal cell carcinoma patients with brain metastases. Cancer (2010) 1.35
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. J Clin Oncol (2009) 1.33
Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Radiat Oncol Biol Phys (2002) 1.27
The prevention and treatment of jet lag. BMJ (2003) 1.27
Strong association of the rest-activity rhythm with well-being in demented elderly women. Am J Geriatr Psychiatry (2007) 1.21
Using the Delphi technique to improve clinical outcomes through the development of quality indicators in renal cell carcinoma. J Oncol Pract (2013) 1.21
Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res (2009) 1.19
Chronotherapy and the molecular clock: Clinical implications in oncology. Adv Drug Deliv Rev (2010) 1.15
Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses. Tumour Biol (2011) 1.13
The circadian rhythm of core temperature: effects of physical activity and aging. Physiol Behav (2006) 1.13
Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Int (2002) 1.12
Quantitative proteomic analysis reveals potential diagnostic markers and pathways involved in pathogenesis of renal cell carcinoma. Oncotarget (2014) 1.11
Sports performance: is there evidence that the body clock plays a role? Eur J Appl Physiol (2009) 1.10
Prognostic factors derived from a prospective database dictate clinical biology of anal cancer: the intergroup trial (RTOG 98-11). Cancer (2010) 1.09
Accelerated treatment using intensity-modulated radiation therapy plus concurrent capecitabine for unresectable hepatocellular carcinoma. Cancer (2009) 1.09
Dynamic microbubble contrast-enhanced US to measure tumor response to targeted therapy: a proposed clinical protocol with results from renal cell carcinoma patients receiving antiangiogenic therapy. Radiology (2011) 1.07
Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma. Mol Cancer (2014) 1.05
Exercise as a synchroniser of human circadian rhythms: an update and discussion of the methodological problems. Eur J Appl Physiol (2006) 1.05
From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma. Mol Cancer (2009) 1.03
Multimodality Treatment With Helical Tomotherapy Intensity Modulated Radiotherapy, Capecitabine, and Photodynamic Therapy is Feasible and Well Tolerated in Patients With Hilar Cholangiocarcinoma. Gastrointest Cancer Res (2008) 1.03
Disruption of circadian coordination accelerates malignant growth in mice. Pathol Biol (Paris) (2003) 1.02
Altered sleep-wake cycles and food intake: the Ramadan model. Physiol Behav (2006) 1.01
Canadian guideline on genetic screening for hereditary renal cell cancers. Can Urol Assoc J (2013) 0.98
Diurnal variation in temperature, mental and physical performance, and tasks specifically related to football (soccer). Chronobiol Int (2007) 0.98
Marker rhythms of circadian system function: a study of patients with metastatic colorectal cancer and good performance status. Chronobiol Int (2002) 0.96
The circadian timing system in clinical oncology. Ann Med (2014) 0.95
Reactivity of ambulatory blood pressure to physical activity varies with time of day. Hypertension (2006) 0.94
A phase II trial of continuous low-dose oral cyclophosphamide and celecoxib in patients with renal cell carcinoma. Cancer Chemother Pharmacol (2006) 0.93
Prediction of overall survival through circadian rest-activity monitoring during chemotherapy for metastatic colorectal cancer. Int J Cancer (2012) 0.92
Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial. Int J Radiat Oncol Biol Phys (2013) 0.89
Jet lag and air travel: implications for performance. Clin Sports Med (2005) 0.89
Spine stereotactic body radiotherapy for renal cell cancer spinal metastases: analysis of outcomes and risk of vertebral compression fracture. J Neurosurg Spine (2014) 0.89
The relevance of melatonin to sports medicine and science. Sports Med (2003) 0.89
Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials. Radiother Oncol (2012) 0.88
Hormonal appetite control is altered by shift work: a preliminary study. Metabolism (2011) 0.88
Treatment of primary liver tumors with Yttrium-90 microspheres (TheraSphere) in high risk patients: analysis of survival and toxicities. Technol Cancer Res Treat (2009) 0.88
Assessment of circadian rhythms by actimetry in healthy subjects and patients with advanced colorectal cancer. Oncol Rep (2003) 0.88
Recursive partitioning analysis of pretreatment variables of 416 patients with locoregional esophageal cancer treated with definitive concomitant chemoradiotherapy on Intergroup and Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys (2004) 0.86
Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963). Chronobiol Int (2011) 0.85
Does external beam radiation therapy improve survival following transarterial chemoembolization for unresectable hepatocellular carcinoma? Gastrointest Cancer Res (2012) 0.85
The effects of circadian rhythmicity and time-awake on a simple motor task. Chronobiol Int (2007) 0.85
The influence of sleep and sleep loss upon food intake and metabolism. Nutr Res Rev (2007) 0.85
Fatigue and weight loss predict survival on circadian chemotherapy for metastatic colorectal cancer. Cancer (2013) 0.84
In vivo detection of apoptotic cells in the testis using fluorescence labeled annexin V in a mouse model of testicular torsion. J Urol (2006) 0.83
Quantifying vascular heterogeneity using microbubble disruption-replenishment kinetics in patients with renal cell cancer. Invest Radiol (2014) 0.82
Diurnal protein expression in blood revealed by high throughput mass spectrometry proteomics and implications for translational medicine and body time of day. Am J Physiol Regul Integr Comp Physiol (2007) 0.81
Preoperative chemoradiation for rectal cancer using capecitabine and celecoxib correlated with posttreatment assessment of thymidylate synthase and thymidine phosphorylase expression. Int J Radiat Oncol Biol Phys (2010) 0.81
Acute diarrhea during adjuvant therapy for rectal cancer: a detailed analysis from a randomized intergroup trial. Int J Radiat Oncol Biol Phys (2002) 0.81
Some chronobiological and physiological problems associated with long-distance journeys. Travel Med Infect Dis (2008) 0.80
Clinical research in pancreatic cancer: the Radiation Therapy Oncology Group trials. Int J Radiat Oncol Biol Phys (2003) 0.80
Effects of one night of partial sleep deprivation upon diurnal rhythms of accuracy and consistency in throwing darts. Chronobiol Int (2009) 0.80
The influence of time awake and circadian rhythm upon performance on a frontal lobe task. Neuropsychologia (2007) 0.80
The use of actimetry to assess changes to the rest-activity cycle. Chronobiol Int (2003) 0.80
Wrist actimetry circadian rhythm as a robust predictor of colorectal cancer patients survival. Chronobiol Int (2014) 0.79
Effects of melatonin on the thermoregulatory responses to intermittent exercise. J Pineal Res (2005) 0.79
The emerging roles of stereotactic ablative radiotherapy for metastatic renal cell carcinoma. Curr Opin Support Palliat Care (2014) 0.78
Effect of time of day on the accuracy and consistency of the badminton serve. Ergonomics (2005) 0.78
Nutritional status and eating habits of bus drivers during the day and night. Chronobiol Int (2014) 0.78
Nutritional intake during a simulated adventure race. Int J Sport Nutr Exerc Metab (2008) 0.77
Nutrition for travel. J Sports Sci (2007) 0.77
Sleep pattern is associated with adipokine levels and nutritional markers in resident physicians. Chronobiol Int (2014) 0.77
Cancer symptom complexes related to alterations in molecular circadian axis signaling. Conf Proc IEEE Eng Med Biol Soc (2006) 0.76
Adipokine levels are altered by shiftwork: a preliminary study. Chronobiol Int (2012) 0.76
The circadian body temperature rhythm of Djungarian Hamsters (Phodopus sungorus) revealing different circadian phenotypes. Physiol Behav (2011) 0.76
Chronobiological considerations for exercise and heart disease. Sports Med (2006) 0.75
Managing jet lag. Sleep Med Rev (2008) 0.75
S100A11 is a potential prognostic marker for clear cell renal cell carcinoma. Clin Exp Metastasis (2016) 0.75
Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys (2005) 0.75
Preoperative stereotactic body radiotherapy to a skull renal cell metastasis: an alternative to preoperative embolization? J Palliat Med (2011) 0.75
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer. Clin Colorectal Cancer (2008) 0.75